APA (7th ed.) Citation

S, H., PH, K., H, K., D, K., S, K., H, D., . . . BH, L. (2026). Therapeutic effects of selumetinib on diffuse neurofibroma and optic pathway glioma in neurofibromatosis type 1. Journal of neuro-oncology, 178(1), . https://doi.org/10.1007/s11060-026-05643-y

Chicago Style (17th ed.) Citation

S, Hwang, Kim PH, Kim H, Kim D, Kim S, Do H, Yoon HM, and Lee BH. "Therapeutic Effects of Selumetinib on Diffuse Neurofibroma and Optic Pathway Glioma in Neurofibromatosis Type 1." Journal of Neuro-oncology 178, no. 1 (2026). https://doi.org/10.1007/s11060-026-05643-y.

MLA (9th ed.) Citation

S, Hwang, et al. "Therapeutic Effects of Selumetinib on Diffuse Neurofibroma and Optic Pathway Glioma in Neurofibromatosis Type 1." Journal of Neuro-oncology, vol. 178, no. 1, 2026, https://doi.org/10.1007/s11060-026-05643-y.